Parabilis Medicines, Inc.
Parabilis Medicines, Inc. scores highest on Anchor (60) and lowest on Price (23). Its PosiPenta is 42.70 out of 100, around the middle of similar companies.
On the Penta Grid this week, Parabilis Medicines, Inc. is Grid #444 of 836 in the Healthcare sector in United States, and Grid #2,619 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Parabilis Medicines, Inc. | 42.70 | 23 | 39 | 31 | 60 | 60 |
| AtriCure, Inc. | 59.90 | 14 | 80 | 92 | 62 | 52 |
| Enliven Therapeutics, Inc. | 50.62 | 21 | 25 | 65 | 75 | 67 |
| Acadia Healthcare Company, Inc. | 51.36 | 34 | 45 | 86 | 35 | 57 |
| Denali Therapeutics Inc. | 44.02 | 20 | 29 | 62 | 53 | 57 |
| Viking Therapeutics, Inc. | 36.21 | 9 | 21 | 38 | 54 | 60 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.39 |
| P/B ratio | 2.68 |
EEarnings
| Trailing EPS | ₹-900.74 |
| Forward EPS | ₹-207.11 |
NNitro
| Price | 2154.77 |
| 52-week high | 4024.44 |
| 52-week low | 2146.24 |
| Fall from 52-week high | 46.5% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.05 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹26,618 Cr |
| Insider holding | 7.03% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Parabilis Medicines, Inc.'s PosiPenta score?
Parabilis Medicines, Inc.'s PosiPenta is 42.70 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Parabilis Medicines, Inc. stand on the Penta Grid?
On the Penta Grid this week, Parabilis Medicines, Inc. is Grid #444 of 836 in the Healthcare sector in United States, and Grid #2,619 of 3,999 in United States.
Which PosiPenta pillar is strongest for Parabilis Medicines, Inc.?
Anchor (stability and dividends), with a score of 60 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Parabilis Medicines, Inc.?
Price (valuation), with a score of 23 out of 100: weaker than most similar companies.
Has Parabilis Medicines, Inc.'s PosiPenta changed since last week?
Yes, it fell 1.48 points, from 44.18 to 42.70.
PositoAI is for research and education only and is not investment advice.